Details for Patent: RE46621
✉ Email this page to a colleague
Which drugs does patent RE46621 protect, and when does it expire?
Patent RE46621 protects COPIKTRA and is included in one NDA.
This patent has forty patent family members in twenty-three countries.
Summary for Patent: RE46621
| Title: | Processes for preparing isoquinolinones and solid forms of isoquinolinones |
| Abstract: | Polymorphs of chemical compounds that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including P13 kinase activity, are described herein. Also provided herein are processes for preparing compounds, polymorphs thereof, and pharmaceutical compositions thereof. |
| Inventor(s): | Pingda Ren, Michael Martin, Paul Isbester, Benjamin S. Lane, Jason Kropp |
| Assignee: | Infinity Pharmaceuticals Inc |
| Application Number: | US15/051,529 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
| Patent landscape, scope, and claims: |
More… ↓ |
Drugs Protected by US Patent RE46621
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Secura | COPIKTRA | duvelisib | CAPSULE;ORAL | 211155-001 | Sep 24, 2018 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| Secura | COPIKTRA | duvelisib | CAPSULE;ORAL | 211155-002 | Sep 24, 2018 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE46621
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 084824 | ⤷ Start Trial | |||
| Argentina | 117467 | ⤷ Start Trial | |||
| Australia | 2012205669 | ⤷ Start Trial | |||
| Australia | 2015258280 | ⤷ Start Trial | |||
| Brazil | 112013017670 | ⤷ Start Trial | |||
| Canada | 2824197 | ⤷ Start Trial | |||
| Chile | 2013002007 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
